Quarterly Results

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE846.00-44.1 (-4.95 %)
PREV CLOSE ( ) 890.10
OPEN PRICE ( ) 924.00
BID PRICE (QTY) 850.00 (10)
OFFER PRICE (QTY) 899.95 (31)
VOLUME 506
TODAY'S LOW / HIGH ( )846.00 930.00
52 WK LOW / HIGH ( ) 535.11303
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
171.15
227.55
183.22
194.31
Total Expenditure
148.86
202.67
166.61
183.88
PBIDT (Excl OI)
22.29
24.88
16.61
10.43
Other Income
1.77
3.56
1.45
4.27
Operating Profit
24.05
28.44
18.06
14.7
Interest
1.01
1.09
0.75
0.98
Exceptional Items
NA
NA
NA
0.48
PBDT
23.04
27.35
17.31
14.2
Depreciation
7.19
7.06
6.75
6.19
Profit Before Tax
15.85
20.29
10.56
8.00
Tax
3.49
5.21
0.56
4.34
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
12.36
15.08
9.99
3.66
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
12.36
15.08
9.99
3.66
Equity Capital
12
12
12
12
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
10.3
12.56
8.33
3.05
Calculated EPS (Annualised)
41.2
50.26
33.33
12.23
No of Public Share Holdings
316100
316100
316100
316100
% of Public Share Holdings
26.34
26.34
26.34
26.34
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
13.02
10.93
9.06
5.36
PBIDTM%
14.05
12.49
9.85
7.56
PBDTM%
13.46
12.01
9.44
7.30
PBTM%
9.26
8.91
5.76
4.12
PATM%
7.22
6.62
5.45
1.88
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.